Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,675 | 30,269 | 33,791 | 36,008 | 37,364 |
| TOTAL | $29,533 | $31,171 | $34,303 | $36,658 | $38,398 |
| Non-Current Assets | |||||
| PPE Net | 662 | 652 | 552 | 554 | 381 |
| Other Non-Current Assets | 3,101 | 3,272 | 1,026 | 1,082 | 1,138 |
| TOTAL | $3,763 | $3,924 | $1,578 | $1,636 | $1,519 |
| Total Assets | $33,296 | $35,095 | $35,881 | $38,294 | $39,917 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 415 | 605 | 958 | 577 | 281 |
| Accrued Expenses | 489 | 926 | 717 | 387 | 440 |
| TOTAL | $1,383 | $2,006 | $1,675 | $964 | $721 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,704 | 1,796 | 0 | 0 | 0 |
| TOTAL | $1,704 | $1,796 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,087 | $3,802 | $1,675 | $964 | $721 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 726 | 725 | 725 | 725 | 725 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -307,739 | -305,828 | -302,328 | -298,823 | -296,291 |
| Other shareholders' equity | -1 | -1 | -1 | -1 | -1 |
| TOTAL | $30,209 | $31,293 | $34,206 | $37,330 | $39,196 |
| Total Liabilities And Equity | $33,296 | $35,095 | $35,881 | $38,294 | $39,917 |